Amantadine to treat cognitive dysfunction in moderate to severe traumatic brain injury

Journal of Trauma Nursing

Volumn 22, Issue 4, 2015, Pages 194-203

  Stelmaschuk, Stephanie ^a   Will, Mary Colleen ^b   Meyers, Tamara ^a  

^a GRANT MEDICAL CENTER   (United States)

^b Central Ohio Primary Care   (United States)

Author keywords

Amantadine; Pharmacologic treatment; TBI; Traumatic brain injury

Indexed keywords

AMANTADINE;

ADULT; BRAIN INJURIES, TRAUMATIC; COGNITION DISORDERS; COMPLICATION; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; GLASGOW COMA SCALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; AMANTADINE; BRAIN INJURIES, TRAUMATIC; COGNITION DISORDERS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLASGOW COMA SCALE; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84942760715     PISSN: 10787496     EISSN: 19323883     Source Type: Journal    
DOI: 10.1097/JTN.0000000000000138     Document Type: Article

References (29)

1. Faul M, Xu L, Wald MM, Coronado VG. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006.. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010.
2. Wheaton P, Mathias JL, Vink R. Impact of early pharmacological treatment on cognitive and behavioral outcome after traumatic brain injury in adult: a meta-analysis. J Clin Psychopharmacol. 2009:29:468-477. doi:10.1097/JCP.0b013e3181b66f04.
3. Warden D, Gordon B, McAllister TW, et al. Guidelines for the pharmacological treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma. 2006;23(10):1468-1501.
4. Rabinowitz AR, Levin HS. Cognitive sequelae of traumatic brain injury. Psychiatr Clin of N Am. 2014;37(1):1-11. doi:10.1016/j. psc.2013.11.004.
5. Kraus MF, Smith GS, Butters M, et al. Effects of the dopaminergic agent and the NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: A study using positron emission tomography (PET). Brain Inj. 2005;19(7):471-479. doi:10.1080/02699050400025059.
6. Hammond FM, Bickett AK, Norton JH, Pershad M. Effectiveness of amantadine hydrochloride in reduction of chronic traumatic brain injury irritability and aggression. J Head Trauma Rehabil. 2014;29:391-399. doi:10.1097/01. HTR.0000438116.56228.de.
7. Fleminger S, Greenwood RRJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury (Review). Cochrane Database Sys Rev. 2006;4: CD003299. doi:10.1002/14651858. CD003299.pub2.
8. Colorado Division of Workers' Compensation. Traumatic Brain Injury Medical Treatment Guidelines. Denver, CO: Colorado Division of Workers' Compensation; 2012:1-119.
9. Chen JJ, Swope DM. Pharmacotherapy for Parkinson's disease. Pharmacotherapy. 2007;27(12):161-173.
10. Meythaler JM, Brunner RC, Johnson A, Novack TA. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17(4):300-313.
11. Saniova B, Drobny M, Kneslova L, Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm. 2004;111:511-514.
12. Giacino JT, Whyte J, Bagiella E, et al. Placebo-controlled trial of amantadine for severe traumatic brain injury. N Engl J Med. 2012;366(9):819-826.
13. Huang EY, Tsui P, Kuo T, et al. Amantadine ameliorates dopamine-releasing deficits and behavioral deficits in rats after fluid percussion injury. PLoS One. 2014;9(1):1-14.
14. Reddy CC, Collins M, Lovell M, Kontos AP. Efficacy of amantadine treatment of symptoms and neurocognitive performance among adolescents following sports-related concussion. J Head Trauma Rehabil. 2013;28(4):260-265. doi:10.1097/HTR.0b013e318257fbc6.
15. Gualtieri CT, Evans RW. Stimulant treatment for the neurobehavioral sequelae of traumatic brain injury. Brain Inj. 1988;2(4):273-290.
16. Schneider WN, Drew-Cates J, Dombovy ML. Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo controlled study. Brain Inj. 1999;13(11):863-872.
17. Hughes S, Colantonio A, Santaguida PL, Paton T. Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Inj. 2005;19:1197-1206.
18. Whyte J, Katz D, Long D, et al. Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: a multicenter study. Arch Phys Med Rehabil. 2005;86:453-462.
19. Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981;44:285-293.
20. Linacre JM, Heineman AW, Wright BD, et al. The structure and stability of the functional independence measure. Arch Phys Med Rehabil. 1994;75:127-132.
21. Ottenbacher KJ, Hsu Y, Granger CV, Fiedler RC. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil. 1996;77(12):1226-1232.
22. Gouvier WD, Blanton PD, La Porte KK, Neomuceno C. Reliability and validity of the Disability Rating Scale and the Levels of Cognitive Functioning Scale in monitoring recovery from severe head injury. Arch Phys Med Rehabil. 1987;68:94-97.
23. Hannay HJ, Ezrachi O, Constant CF, Levin HS. Outcome measures for patients with head injuries: report of the outcome measures subcommittee. J Head Trauma Rehabil. 1996;11:41-50.
24. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
25. Kraus MF, Maki P. Effect of amantadine hydrochloride on symptoms of frontal lobe dysfunction in brain injury: case studies and review. J Neuropsychiatry Clin Neurosci. 1997;9:222-230.
26. Kraus MF, Maki P. The combined use of amantadine and ldopa/carbidopa in treatment of chronic brain injury. Brain Inj. 1997;11(6):445-460.
27. Rowly G, Fielding K. Reliability and accuracy of the Glasgow Coma Scale with experienced and inexperienced users. Lancet. 1991;337(8740):535-538.
28. Gill MR, Reiley DG, Green SM. Interrater reliability of Glasgow Coma Scale scores in the emergency department. Ann Emerg Med. 2004;43(2):215-223.
29. Brain Trauma Foundation. Guidelines on the management of severe traumatic brain injury, 3rd edition. J Neurotrauma. 2007;24:S1-S119.